Zaid et al. observed that when the expression levels of FGFR4 and FGF19 are decreased, it significantly reduces tumor growth in vivo and in vitro in ovarian cancer [48] and in the cell line of colon cancer. The gene discussed is FGF19; the disease is ovarian carcinoma.